F. Hoffmann-La Roche Ltd Digital Transformation Strategy Analysis Report 2023: Technology Focus, Initiatives, Roche Venture Fund, Investments, Acquisitions, Partnerships, ICT Budget and Contracts

DUBLIN, Jan. 12, 2024 /PRNewswire/ — The “F. Hoffmann-La Roche Ltd – Digital Transformation Strategies” company profile has been added to ResearchAndMarkets.com’s offering.


This report provides insight into Roche’s technology activities, including insights into its digital transformation strategies and accelerator/incubator and other innovation programs. It provides an overview of technology initiatives covering partnerships, product launches, investments and acquisitions and Insights on each technology initiative including technology theme, objective, and benefits. It also provides details of estimated ICT budgets and major ICT contracts.

F. Hoffmann-La Roche Ltd (Roche) is a healthcare company that develops drugs and diagnostics devices for treating diseases. It provides medicines and diagnostics for oncology, immunology, neuroscience, ophthalmology, infectious diseases, respiratory, and other areas. The company also provides in-vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions.

The company offers its products and services to hospitals, commercial laboratories, healthcare professionals, researchers, and pharmacists. In 2021, pharmaceuticals accounted for the major share of the company’s revenue.


  • Roche is exploring and utilizing technologies including artificial intelligence, cloud, big data, blockchain, and quantum computing to achieve operational efficiency and launch innovative products.
  • Roche has invested in healthtech companies that are using machine learning tools to accelerate diagnosis of cancer and discover biomarkers.

Reasons to Buy

  • Gain insights into Roche’s technology activities.
  • Gain insights into its digital transformation strategies and innovation initiatives.
  • Gain insights into its technology themes under focus.
  • Gain insights into its various product launches, partnerships, investment and acquisition strategies.

Key Topics Covered:

  • Overview
  • Digital Transformation Strategy
  • Accelerators, Incubators, and Other Innovation Programs
  • Technology Focus
  • Technology Initiatives
  • Venture Arm: Roche Venture Fund
  • Investment
  • Acquisitions
  • Partnership and Investment Network Map
  • ICT Budget and Contracts
  • Key Executives
  • Contact Us

A selection of companies mentioned in this report includes

  • Ibex Medical Analytics
  • Medial EarlySign
  • Recursion
  • PathAI
  • Genesis Therapeutics
  • Sensyne Health
  • Wellthy Therapeutics
  • Flywheel
  • AWS
  • Microsoft
  • Google
  • Veeva Systems
  • SAP
  • Tenthpin
  • Alan Turing Institute
  • GE Healthcare
  • Cambridge Quantum
  • Novo Nordisk
  • Lilly
  • Temedica
  • Diabeloop
  • Ocean Protocol
  • Flatiron Health
  • Viewics
  • Prescient Design
  • Freenome
  • Second Genome.

For more information about this company profile visit https://www.researchandmarkets.com/r/cg1cjw

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg


Cision View original content:https://www.prnewswire.com/news-releases/f-hoffmann-la-roche-ltd-digital-transformation-strategy-analysis-report-2023-technology-focus-initiatives-roche-venture-fund-investments-acquisitions-partnerships-ict-budget-and-contracts-302033679.html

SOURCE Research and Markets

F. Hoffmann-La Roche Ltd Digital Transformation Strategy Analysis Report 2023: Technology Focus, Initiatives, Roche Venture Fund, Investments, Acquisitions, Partnerships, ICT Budget and Contracts WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles